
Halozyme Therapeutics Added to Russell 1000 Index
Halozyme Therapeutics, announced that it has been added to the U.S. large-cap Russell 1000 Index, effective after market close on June 27th, as part of the 2025
Halozyme Therapeutics, announced that it has been added to the U.S. large-cap Russell 1000 Index, effective after market close on June 27th, as part of the 2025
Fuel up with free Health Tech Insights